HMS
BPMC

Hanseatic Management Services’s Blueprint Medicines BPMC Stock Holding History

Hanseatic Management Services’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-19
Closed -$2K – 399
2018
Q1 		$2K Hold
19
– – ﹤0.01% 331
2017
Q4 		$1K Hold
19
– – ﹤0.01% 369
2017
Q3 		$1K Hold
19
– – ﹤0.01% 377
2017
Q2 		$1K Hold
19
– – ﹤0.01% 372
2017
Q1 		$1K Hold
19
– – ﹤0.01% 352
2016
Q4 		$1K Buy
+19
New +$573 ﹤0.01% 279

Other funds holding BPMC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
HIM
Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Hanseatic Management Services's BPMC Position: Q2 2018 in Review

Hanseatic Management Services sold out of Blueprint Medicines (BPMC) in Q2 2018, closing a stake of 19 shares — an estimated $2K sold.

Hanseatic Management Services first reported a position in BPMC in Q4 2016 and held it in 6 quarters. The position peaked at $2K in Q1 2018. 181 funds tracked by Wall St. Rank hold BPMC as of Q2 2018.

  • Hanseatic Management Services reported no remaining Blueprint Medicines position as of Q2 2018 after selling out during the quarter.
  • Hanseatic Management Services sold 19 Blueprint Medicines shares in Q2 2018, an estimated $2K.
  • Hanseatic Management Services first reported a position in Blueprint Medicines in Q4 2016 and held it in 6 quarters.
  • Hanseatic Management Services's Blueprint Medicines position peaked at $2K in Q1 2018.
  • 181 funds tracked by Wall St. Rank held Blueprint Medicines as of Q2 2018.

Based on Hanseatic Management Services's 13F filing for Q2 2018, filed 14 Aug 2018.